Skip to content
No results
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact

Hello, feel free to inquire - up to 50% OFF!

dengyuemed logo
China Medicine Wholesaler
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
dengyuemed logo
China Medicine Wholesaler
china approves imipenem-cilastatin-funobactam for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
News

China Approves Imipenem-Cilastatin-Funobactam: First BL/BLI Combination Targeting Three Major Carbapenem-Resistant Bacterial Groups

DengYueMed, DengYue 17/11/2026
fda approves novel chinese drug pimicotinib for tenosynovial giant cell tumor
News

FDA Approves Novel Chinese Drug Pimicotinib for Tenosynovial Giant Cell Tumor (TGCT)

DengYueMed, DengYue 12/11/2026
lymphoma car-t therapy im19 approved in china for relapsed or refractory lbcl
News

Lymphoma CAR-T Therapy IM19 Approved in China for Relapsed or Refractory LBCL

DengYueMed, DengYue 10/11/2026
bayer asundexian approved in china for stroke prevention
News

Bayer’s Asundexian Approved in China: A Novel FXIa Inhibitor for Stroke Prevention

DengYueMed, DengYue 29/10/2026
new drug batoclimab for myasthenia gravis approved in china
News

New Drug Batoclimab for Myasthenia Gravis Approved in China, Advancing FcRn-Targeted Therapy

DengYueMed, DengYue 24/10/2026
iberdomide approved in china the world’s first celmod drug for multiple myeloma
News

Iberdomide Approved in China: The World’s First CELMoD Drug for Multiple Myeloma

DengYueMed, DengYue 10/10/2026
sanofi rilzabrutinib approved in china first btk inhibitor for immune thrombocytopenia itp
News

Sanofi’s Rilzabrutinib Approved in China: First BTK Inhibitor for Immune Thrombocytopenia (ITP)

DengYueMed, DengYue 23/09/2026
innovative lung cancer drug asandeutertinib approved in china
News

Innovative Lung Cancer Drug Asandeutertinib Approved: Deuterated Third-Generation EGFR-TKI for Brain Metastases

DengYueMed, DengYue 18/09/2026
innovative plaque psoriasis drug lecankitug approved in china
News

Innovative Plaque Psoriasis Drug Lecankitug Approved: The World’s Second IL-17A/F Dual-Target Drug

DengYueMed, DengYue 16/09/2026
innovative multiple myeloma drug velinotamig approved in china
News

Innovative Multiple Myeloma Drug Velinotamig Approved in China for R/R Patients After Multiple Lines of Treatment

DengYueMed, DengYue 05/09/2026
fanregratinib approved for intrahepatic cholangiocarcinoma in china
News

Fanregratinib Approved for Intrahepatic Cholangiocarcinoma in China: A Novel Oral FGFR1/2/3 Inhibitor

DengYueMed, DengYue 04/09/2026
icotrokinra approved in china for plaque psoriasis the worlds first oral il 23r targeted drug
News

Icotrokinra Approved in China for Plaque Psoriasis: The World’s First Oral IL-23R-Targeted Drug

DengYueMed, DengYue 28/08/2026
Quick Links
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
Get In Touch
  • Phone: +852-56986617
  • Whats APP: +852-56986617
  • Fax: +852-56986617
  • Email: inquiry@dengyuemed.com
  • Address: 6/F, Tai Tak Industrial Building, New Territories, Hong Kong
X-twitter Facebook Youtube Linkedin Instagram

Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights

WhatsApp us